trials continue..., page-5

The SP went from 14c to 24c in one day on news that their drug not only cured cancer in a mouse but induced immunity. These experiments are being extended into a pre-clinical study which aims to confirm and extend preliminary findings, announced in November
2004, that combination therapy in mice may induce lasting immunity to malignant mesothelioma which may then result in a cure. The experiments were expected to be completed in June 2005 (overdue). See the announcement on Solbec's website...

http://www.solbec.com.au/pdfs/ASX030205.pdf